Sign in
Topical Costus sp. Preparation as Palliative Care for Chemotherapy-Induced Peripheral Neuropathy of Patients: A Randomized Placebo-Controlled Pilot Trial
Journal article   Peer reviewed

Topical Costus sp. Preparation as Palliative Care for Chemotherapy-Induced Peripheral Neuropathy of Patients: A Randomized Placebo-Controlled Pilot Trial

Ghazaleh Heydarirad, Holger Cramer, Rasoul Choopani, Reyhaneh Gharehgozlou, Seyed Hamdollah Mosavat, Ahmad Ameri and Mehdi Pasalar
The journal of alternative and complementary medicine (New York, N.Y.), Vol.26(9), pp.809-814
18/09/2020
PMID: 32924550

Metrics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Abstract

Administration, Topical Adult Aged Antineoplastic Agents - adverse effects Costus Feasibility Studies Neoplasms - drug therapy Neuralgia - etiology Neuralgia - therapy Ointments Palliative Care Patient Dropouts Phytotherapy Pilot Projects Plant Oils - therapeutic use
Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of various anticancer regimens with different sensory-motor abnormalities in patients. The aim of this study was to examine the feasibility of using Costus sp. oil as a palliative treatment in such patients.

Details